CombiMatrix Enters Microarray Joint Venture With Japanese Conglomerate

Oct 29, 2001

NEW YORK, Oct. 29 - Microarray company CombiMatrix has launched a joint venture with the Japanese trading company Marubeni Japan, CombiMatrix announced on Monday.

The project will help CombiMatrix, a subsidiary of Pasadena, Calif.-based Acacia Research, to develop a market for its microarray technology with Japanese pharmaceutical and biotech companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Synthetic Genomics Sued for Gender Discrimination

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Football Team's DNA Day Postponed

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

This Week in Cell

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Main menu